A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial

OBJECTIVE: Pharmacogenomic-based antidepressant treatment (PGATx) may result in more precise pharmacotherapy of major depressive disorder (MDD) with better drug therapy guidance. METHODS: An 8-week, randomized, single-blind clinical trial was conducted to evaluate the effectiveness and tolerability...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Psychopharmacol Neurosci
Main Authors: Han, Changsu, Wang, Sheng-Min, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S., Mandelli, Laura, Pae, Chi-Un, Serretti, Alessandro
פורמט: Artigo
שפה:Inglês
יצא לאור: Korean College of Neuropsychopharmacology 2018
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245286/
https://ncbi.nlm.nih.gov/pubmed/30466219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2018.16.4.469
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים